During the past decade, Henry Ford Health System, Dept of Ophthalmology and Eye Care Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services" #1 collaborator was "National Eye Institute (NEI)" with 9 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services" are "Diabetic Macular Edema" (7 trials), "Diabetic Retinopathy" (4 trials), "Proliferative Diabetic Retinopathy" (2 trials), "Vitreous Hemorrhage" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services" in a lesser frequency.

Most popular intervention types in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services" are "Drug" (8 trials), "Procedure" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Prompt aflibercept" (2 trials), "0.3 mg intravitreal ranibizumab" (1 trials) and "1.25 mg intravitreal bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Henry Ford Health System, Dept of Ophthalmology and Eye Care Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Henry Ford Health System, Dept of Ophthalmology and Eye Care Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Health System, Dept of Ophthalmology and Eye Care Services, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".